Dr. Carpenter is researching how T cells respond to tuberculosis in the hopes of preventing active TB disease.

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, ...

Engineers from MIT have put together a 3D-printed device that can release medicine under the skin with a wireless trigger.

11,000 more TB patients died after Trump's USAID cuts. That number will rise. | Opinion More than 11,000 additional TB patients are estimated to have died after USAID funding freeze. If this ...

Scientists at the University of Hong Kong in China are experimenting with 3D-printing functional organ tissue, a step towards the future.

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide.

Through technological innovation and the development of new tuberculosis vaccines, ASEAN countries play a vital role in combating TB at both regional and global levels.

Tuberculosis kills 1.3 million people each year, making it the deadliest infectious disease in the world, write KJ Seung and Kunda Kwabisha Mikanda. Eliminating U.S. funding to combat it around ...

Koppens and colleagues reported on their findings in PLOS Biology in a paper titled “ Correction of pathogenic mitochondrial DNA in patient-derived disease models using mitochondrial base ...

The Total Care Model takes the same physicians, the same patients and the same payors, and moves them from the challenges of FFS into a total care relationship, which results in high-quality care ...

Patient recruitment remains a major bottleneck in clinical trial execution, with inefficient patient-trial matching often causing delays and failures. Recent advancements in large language models ...

Once thought to have originated in cows and spread through dust, the surprising evolutionary story of tuberculosis reveals why it's so hard to stamp out this ancient disease, writes Carl Zimmer ...